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Lymphocyte signaling: Adapting new adaptors
Christopher E. Rudd
New developments in lymphocyte signaling have
revealed insights into the proximal phosphorylation
events associated with the T-cell receptor and into the
importance of the T-cell adaptor protein Slp-76 and its
B-cell homolog in the transduction of the signal from
the antigen receptor.
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The antigen receptors on T and B lymphocytes — the 
T-cell receptor (TCR) and B-cell receptor (BCR), respec-
tively — are multimeric complexes comprising a receptor
module that is non-covalently associated with various sig-
naling proteins (CD3 and the TCRζ chain in T cells and
immunoglobulin α and β in B cells). These complexes ini-
tiate intracellular signaling by engaging proximal protein
tyrosine kinases of the Src kinase family. The association of
the T-cell-specific Src-family kinase Lck with the CD4 and
CD8 T-cell co-receptors brings the kinase into proximity
with the TCRζ–CD3 complex, thereby promoting tyrosine
phosphorylation of immunoreceptor tyrosine-based activa-
tion motifs (ITAMs) on the TCRζ and CD3 chains. The
phosphorylation of the two tyrosine residues in the ITAM
allows the Src homology 2 (SH2) domains of another lym-
phoid-specific kinase, Zap-70, to bind in tandem to the
TCR. Subsequent Lck-mediated phosphorylation of Zap-
70 is then needed for Zap-70 activation and the phosphory-
lation of downstream targets. The SH2 domain of Lck can
also bind to Zap-70 thereby consolidating the presence of
CD4–Lck or CD8–Lck in the TCRζ–CD3 complex.
Unlike growth factor receptors, TCRζ–CD3 complexes are
not simple binary on–off signaling switches. Instead, the
peptide ligand of the TCR, as presented in the peptide-
binding groove of a major histocompatibility complex
(MHC) molecule, can induce a range of responses — nega-
tive responses if it is an antagonist, partial responses if a
partial agonist and optimal activation if an agonist. The
level of response depends on the avidity of peptide
binding, on the on–off rates and on the degrees of receptor
aggregation. In an exciting new study, Neumeister Kersh et
al. [1] have shed new light on the molecular basis by which
these quantitative differences in binding can potentially be
translated into qualitatively different biological responses.
Previous studies had shown that the three distinct ITAMs
of the TCRζ chain are critical for a response to the
MHC–peptide complex. The TCRζ chain is found as an
unphosphorylated 16 kDa species and as a partially phos-
phorylated 21 kDa species in resting T cells, undergoing
further phosphorylation to a 21 kDa and/or a 23 kDa
species upon receptor crosslinking. Using antisera specific
for the individual phosphorylation sites of the three
ITAMs, Neumeister Kersh et al. [1] uncovered an ordered,
hierarchical mode by which the individual sites become
phosphorylated in response to different types of peptide.
In this scheme, the phosphoryation of one tyrosine residue
required the presence of another. Further, while the TCRζ
chain in resting T cells has monophosphorylated ITAMs,
partial agonist peptides induce a discrete pattern of phos-
phorylation amongst individual ITAMs and potent agonists
cause the phosphorylation of all ITAMs. Phosphorylation
of the last two tyrosines in the sequence depended directly
on the strength of the agonist. The expectation from these
studies is that different stages of ordered phosphorylation
will be found to differentially engage the effector of the
response — Zap-70 and/or some other molecule. In this
context, monophosphorylated ITAMs in resting T cells
were sufficient for the recruitment of one Zap-70 mole-
cule, while fully phosphorylated ζ could recruit as many as
three Zap-70 molecules. The process may be more subtle
than this, however, because results indicate that the pro-
gressive phosphorylation of intermediate forms of TCRζ
— and thus the progressive recruitment of Zap-70 — did
not necessarily lead to Zap-70 activation.
Although the TCRζ chain is the focus of early molecular
changes, it is not the only member of the receptor
complex with the potential to generate intracellular
signals. Bruyns et al. [2] have recently identified a new
dimeric structure (termed TRIM for T-cell receptor inter-
acting molecule) that loosely associates with the receptor
complex. TRIM is a member of a growing family of
dimeric type III transmembrane proteins, which have a
short extracellular region attached to an extended cyto-
plasmic tail. As with the TCRζ chain, the small extracellu-
lar region of TRIM is unlikely to bind directly to ligand.
Instead, it may act as a cell-surface adaptor that is engaged
by adjacent receptors. Interestingly, instead of possessing
ITAMs, TRIM has six tyrosine residues in its intracellular
region that include SH2-domain-binding motifs for Src
kinases and for phosphatidylinositol 3-kinase. TRIM is
therefore unlikely to be a simple homolog of TCRζ, and
instead carries the potential to induce signaling pathways
that are linked to other functions. An analogous molecule
is the previously cloned type III transmembrane protein
LAT (linker for activation of T cells) which associates
with numerous SH2-domain-containing signaling proteins,
such as the adaptor protein Grb2, phosphatidylinositol 3-
kinase, phospholipase Cγ (PLCγ) and others [3]. 
In addition to elucidating cell-surface events, rapid recent
progress has also been made in identifying downstream
targets of the T-cell signaling cascade. A key issue con-
cerns the mechanism by which proximal lymphoid-
restricted signaling proteins connect with more general
signal transducers, such as PLCγ and Ras, and the degree
to which this is linked to the regulation of immune-spe-
cific functions. Studies over the past couple of years have
identified several key lymphoid-restricted signaling pro-
teins, including Slp-76 (SH2-domain-containing leucocyte
protein of 76 kDa), Fyb (FynT-binding protein, FynT
being the T-cell-specific isoform of the Src-family kinase
Fyn) or Slap (for Slp-76-associated protein), and Skap55
(Src-kinase-associated protein of 55 kDa). Each protein
has a unique amino-terminal region with either a SH2 or
SH3 domain at the carboxyl terminus. Each also under-
goes an increase in tyrosine phosphorylation in response to
TCR crosslinking. Of particular interest is Slp-76 [4], a
downstream target of Zap-70 [5,6]. One remarkable
feature of this protein is its ability to bind to multiple
effector proteins such as PLCγ, the adaptor proteins Grb2
and Nck, and the hematopoietic GTP-exchange protein
Vav (Figure 1). In this regard, Slp-76 has the potential to
act as a central adaptor protein that links the TCR to the
activation of lipid metabolism (via PLCγ), serine/threo-
nine kinases and GTP-binding proteins such as Ras, Rho
and Rac (via Vav). Slp-76 has a central proline-rich region
with several tyrosine phosphorylation sites and has a
carboxy-terminal SH2 domain. The proline residues inter-
act with SH3-domain-containing proteins such as Grb2,
while two tyrosine-based motifs interact with the SH2
domain of Vav. Furthermore, overexpression of Slp-76 can
augment TCR-induced transcription of the T-cell growth
factor interleukin-2, a key consequence of TCR signaling;
this effect is dependent on the SH2 domain of Slp-76. 
In addition to binding general downstream effector pro-
teins, Slp-76 binds to lymphoid-specific proteins. The
SH2 domain of Slp-76 binds to at least two proteins, one
of which corresponds to the lymphoid-specific protein
Fyb/Slap [7,8]. Fyb/Slap is expressed only in T cells and
myeloid cells, and it has a several proline-rich regions,
multiple tyrosine-containing motifs and two putative
nuclear localization sequences linked to a carboxy-termi-
nal SH3-like domain. Two Fyb/Slap isoforms of 120 kDa
and 130 kDa are known, which differ because of a 46
amino-acid insert in the 130 kDa form between the two
nuclear localization sequences (my group’s unpublished
observations). In an unusual twist, Fyb/Slap is phosphory-
lated by and binds selectively to the SH2 domain of
FynT. This provides a specific avenue by which the
FynT kinase could intervene in signaling. Although the
details are still unclear, overexpression of Fyb/Slap has
been found to slightly increase interleukin-2 release [7]
and to have either no effect or a negative effect on inter-
leukin-2 transcription [7,8].
In addition to these players, Liu et al. [9], using a two-
hybrid screen, have recently identified two new Fyb-
binding proteins that correspond to the previously cloned
Skap55 [10] and a new Skap55-related protein (Skap55R).
In this case, the SH3 domains of Skap55 and Skap55R
bind to Fyb. Skap55 has a central pleckstrin homology
domain and a carboxy-terminal SH3 domain. Skap55R
has a similar overall structure to Skap55, except that
Skap55R has a coiled-coil loop at the amino terminus.
Coiled-coil domains tend to bind tightly to each other and
are found in fibrous proteins, such as tropomyosin, as well
as transcriptional activators, such as the homeobox-con-
taining protein Ubx. Thus, while Skap55R might gener-
ate similar signals to Skap55, it may also differ in its
intracellular localization and/or generate unique signals
due to its coiled-coil region. As with Fyb/Slap, Skap55
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Figure 1
A central role for Slp-76 in T-cell signaling. Signaling from the TCR is
mediated by proximal events such as the activation of Lck and Zap-70.
The activation of Zap-70 then leads to the phosphorylation of Slp-76
and LAT. Slp-76 phosphorylation facilitates binding of the SH2 domain
of Vav. Slp-76 expression is required for PLCγ phosphorylation,
increased Ca2+ influx, Erk activation and CD69 expression. Ultimately,
Slp-76 is needed for increased NFAT/AP-1 transcriptional activity on
the interleukin-2 promoter. Slp-76 also binds to the lymphoid protein
Fyb/Slap which binds to Skap55 and Skap55R. 
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Given this array of newly identified lymphoid proteins,
what then is their function? Three recent papers have
reported exciting evidence for a central role for Slp-76 in
signaling from the TCR in mature T cells, and in signal-
ing in immature thymocytes via the pre-TCR which com-
prises a TCRβ chain and a pTα chain [11–13]. Upon
reaching the thymus, the newly seeded thymocyte under-
goes differentiation and the stages of this process can be
characterized by changes in expression of cell-surface
markers, commonly the co-receptors CD4 and CD8
(Figure 2). The earliest thymocytes progress from a
CD4–CD8– (double negative, DN) stage to a CD4+CD8+
(double positive, DP) stage and in their fully differenti-
ated form express only one of the co-receptors, being
CD4+ or CD8+ (single positive, SP). Slp-76-deficient thy-
mocytes show a profound block at a specific step during
the differentiation of DN thymocytes (which is further
characterized by cell-surface markers as being
CD25+CD44–) [11,12]. At this point under normal condi-
tions the TCRβ chain is rearranged and the pre-TCR
assembles; pre-TCR signaling can then induce progres-
sion to DP cells. Although they showed normal TCRβ
chain rearrangement, Slp-76-deficient thymocytes were
defective in pre-TCR signaling as demonstrated by the
inability of pre-TCR crosslinking to induce the appear-
ance of DP cells [12]. An additional defect in the Slp-76-
deficient mice was severe hemorrhaging — possibly due
to an effect on platelets — which resulted in decreased
viability. Slp-76 is therefore required for the pre-TCR
signaling events that mediate progression from the DN to
DP stage of thymic development. 
Perhaps not surprisingly, given the kinase–substrate rela-
tionship between Zap-70 or Syk and Slp-76, Slp-76-defi-
cient mice have a similar phenotype to mice which lack
both Zap-70 and Syk expression [14]. This finding could
be interpreted to imply a cause–effect connection
between kinase and substrate in pre-TCR signaling. It is
questionable whether the ability of Zap-70 to promote
Vav binding to Slp-76 is important in this pathway,
because DP thymocytes develop normally in Vav-defi-
cient mice. By contrast, like Slp-76-deficient mice, Lck-
deficient mice also show a partial block at the DN stage,
but are additionally defective in β-chain rearrangement.
This finding points to a distinction between Lck and Slp-
76 in which Lck is required for a further earlier event in
differentiation. Nevertheless, mice lacking Lck and Fyn
show a complete arrest at the DN stage indicating that
both of these Src-related kinases are also needed for pre-
TCR signaling [15,16]. Slp-76 could therefore act as a
common downstream target for upstream signals gener-
ated by the Lck, Fyn, Zap-70 and Syk kinases.
As well as being required for pre-TCR signaling, Slp-76 is
necessary for signaling from the mature TCR. A study by
Yablonski et al. [13] using a Slp-76-deficient T-cell line
outlined a more detailed view of the connection between
Slp-76 and other signaling events (Figure 1). In these cells,
many events were reduced or absent, including activation
of the mitogen-activated protein kinase Erk2, phosphoryla-
tion of PLCγ1, production of inositol phosphates, increases
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Slp-76-deficient mice show a profound block at the CD4–CD8– stage
of thymocyte development. Thymocytes pass through various stages of
differentiation that can be identified by cell-surface markers as detailed
in the text and summarized in the figure. Slp-76-deficient thymocytes
show an arrest in CD25+CD44– DN stage with a defect in pre-TCR
signaling. Slp-76-deficient mice most closely resemble mice lacking
expression of Zap-70 and Syk, which also show a block at the DN
stage after having undergone successful β-chain rearrangement.
in intracellular Ca2+ concentration, and expression of the
activation marker CD69. TCR crosslinking was completely
uncoupled from transcriptional activation of the inter-
leukin-2 promoter mediated by the transcription factor
NFAT, and partially uncoupled from activation of the pro-
moter by the transcription factor AP-1. An important
finding was that the loss of PLCγ1 phosphorylation
occurred without a loss in tyrosine phosphorylation of other
substrates. This points to a specific scaffolding role for Slp-
76 in bridging a protein tyrosine kinase with PLCγ1. 
Slp-76-deficient mice showed no obvious defects in B-cell
development or function [11,12] suggesting the existence
of a B-cell homolog of Slp-76. Indeed, two recent studies
have identified such a potential homolog termed Blnk (B
cell linker protein)/Slp-65 [17,18] (Figure 3). Notably,
Blnk/Slp-65 has the same overall structure as Slp-76 and
can bind to PLCγ, Grb2, Vav and Nck. Blnk/Slp-65 also
activates PLCγ activity and upregulates NFAT activity
[17]. Slp-76 and Blnk/Slp-65 have therefore co-evolved as
adaptors linking the antigen receptors with downstream
signaling processes. The rationale for different forms of
the protein in T and B cells may relate to their different
regulatory effects on Erk kinases. Unlike Slp-76,
Blnk/Slp-65 failed to activate the kinase in transfection
studies. We cannot exclude an additional possibility that
these proteins might use the more general signaling path-
ways to provide an appropriate signaling background for
the mediation of lymphoid-specific functions through
their interaction with Fyb/Slap and a potential B-cell
homolog. Functional and knock-out studies on Fyb/Slap
and Skap55 and their potential B-cell homologs will
provide an exciting sequel to the studies of Slp-76.
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Figure 3
The Slp-76 homolog Blnk/Slp-65 in B cells. Signaling from the BCR is
mediated by antigen receptor complex crosslinking followed by
activation of Fyn, Lyn, Blk, Syk and Btk. Blnk/Slp-65 has the same
overall structure as Slp-76, and shares the ability to bind PLCγ, Grb2,
Vav and Nck. The identification of Blnk/Slp-65 points to the conserved
nature of basic signaling mechanisms in B and T cells.
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